Exome Asset Management’s Insmed INSM Stock Holding History

Exome Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48M	Sell	13,873 -12,778	-48%	-$1.55M	0.91%	41
2026 Q1	$4.36M	Buy	+26,651	New	+$4.1M	2.25%	12
2024 Q4	–	Sell	-33,600	Closed	-$2.45M	–	71
2024 Q3	$2.45M	Sell	33,600 -23,200	-41%	-$1.71M	1.66%	26
2024 Q2	$3.81M	Sell	56,800 -14,900	-21%	-$578K	3.39%	7
2024 Q1	$1.95M	Buy	71,700 +10,200	+17%	+$285K	1.67%	22
2023 Q4	$1.91M	Buy	+61,500	New	+$1.59M	1.88%	23

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Exome Asset Management's INSM Position: Q2 2026 in Review

Exome Asset Management reduced its Insmed (INSM) stake by 48% in Q2 2026, selling an estimated $1.55M and leaving 13,873 shares worth $1.48M. The position accounts for 0.91% of the portfolio, ranked #41.

Exome Asset Management first reported a position in INSM in Q4 2023 and has held it in 6 quarters since. The position peaked at $4.36M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Exome Asset Management held 13,873 shares of Insmed worth $1.48M as of Q2 2026.
Exome Asset Management sold 12,778 Insmed shares in Q2 2026, an estimated $1.55M.
Insmed made up 0.91% of Exome Asset Management's portfolio in Q2 2026, its #41 holding.
Exome Asset Management first reported a position in Insmed in Q4 2023 and has held it in 6 quarters since.
Exome Asset Management's Insmed position peaked at $4.36M in Q1 2026.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.